par 727 par 727 Pill - brown white capsule/oblong, 19mm
Pill with imprint par 727 par 727 is Brown / White, Capsule/Oblong and has been identified as Doxycycline Monohydrate 100 mg. It is supplied by Par Pharmaceutical Inc.
Doxycycline is used in the treatment of Actinomycosis; Acne; Amebiasis; Anthrax; Gonococcal Infection, Uncomplicated and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for par 727 par 727




Doxycycline Monohydrate
- Imprint
- par 727 par 727
- Strength
- 100 mg
- Color
- Brown / White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antimalarials, Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical Inc.
- Inactive Ingredients
-
silicon dioxide,
gelatin,
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
titanium dioxide,
D&C Yellow No. 10,
ferrosoferric oxide,
ferric oxide red,
ferric oxide yellow,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
49884-0727 (Discontinued) | Par Pharmaceutical, Inc. |
68084-0743 (Discontinued) | Amerisource Health Services |
More about doxycycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,635)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous antimalarials
- Breastfeeding
- En español
Patient resources
Other brands
Vibramycin, Monodox, Doryx, Oracea, ... +8 more
Professional resources
- Doxycycline monograph
- Doxycycline (Topical) (AHFS Monograph)
- Doxycycline Hyclate (EENT) (AHFS Monograph)
- Doxycycline (FDA)
- Doxycycline Delayed Release Capsule (FDA)
Other brands
Vibramycin, Monodox, Doryx, Oracea, ... +7 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.